By Femtech Insider Cancer, News, Pharma December 10, 2024 ShareTwitterFacebookPinterest-circled Merck Announces Positive Results for Ovarian Cancer Treatment Trial
By Femtech Insider Cancer, News, Pharma, Regulatory November 18, 2024 ShareTwitterFacebookPinterest-circled AbbVie’s ELAHERE Receives EU Approval for Treating Platinum-Resistant Ovarian Cancer
By Femtech Insider Acquisition, Brain Health and Cognitive Health, News, Pharma October 30, 2024 ShareTwitterFacebookPinterest-circled AbbVie to Acquire Aliada Therapeutics for $1.4B, Expanding Alzheimer’s Pipeline
By Femtech Insider Acquisition, News, Pharma October 30, 2024 ShareTwitterFacebookPinterest-circled Organon Completes $1.2B Dermavant Acquisition as FDA Decision on Atopic Dermatitis Indication Nears
By Femtech Insider Breast Health, Cancer, News, Pharma, Regulatory October 16, 2024 ShareTwitterFacebookPinterest-circled FDA Approves Genentech’s Itovebi for Advanced Breast Cancer with PIK3CA Mutation
By Femtech Insider Breast Health, Cancer, News, Pharma October 1, 2024 ShareTwitterFacebookPinterest-circled FDA Approves Novartis’ Kisqali for Early Breast Cancer
By Femtech Insider Acquisition, News, Pharma September 19, 2024 ShareTwitterFacebookPinterest-circled Organon to Acquire Roivant’s Dermatology Subsidiary for Up to $1.2B
By Femtech Insider Fertility, News, Pharma, Reproductive Health September 16, 2024 ShareTwitterFacebookPinterest-circled Organon Partners with BaoPharma to Bring Innovative Long-Acting FSH Treatment to China
